Table 3 Univariate predictors of hard endpoints and MACE
Clinical characteristics | Cardiac Death or Nonfatal MI (N = 18-1.6%) | P Value | MACE (N = 54 - 4.7%) | P Value |
|---|---|---|---|---|
Male | 1.42 (0.56-23.57) | 0.460 | 1.13 (0.66-1.93) | 0.655 |
Body mass index > 25 kg/m2 | 0.25 (0.08-0.77) | 0.016 | 0.72 (0.42-1.22) | 0.220 |
Age (per 10 year increment) | 0.94 (0.63-1.40) | 0.756 | 1.15 (0.90-1.48) | 0.256 |
Smoking | 0.48 (0.06-3.61) | 0.475 | 0.67 (0.24-1.85) | 0.437 |
Hypercholesterolemia | 0.95 (0.37-2.44) | 0.909 | 1.22 (0.69-2.15) | 0.487 |
Diabetes mellitus | 1.058 (0.62-4.00) | 0.335 | 2.01 (1.18-3.42) | 0.010 |
Hypertension | 0.73 (0.29-1.86) | 0.514 | 1.10 (0.63-1.93) | 0.730 |
Prior chest pain | 0.30 (0.10-0.90) | 0.032 | 0.84 (0.49-1.44) | 0.523 |
Prior dyspnea | 0.95 (0.37-2.46) | 0.922 | 0.82 (0.47-1.43) | 0.473 |
Prior heart failure | 1.58 (0.56-5.85) | 0.235 | 2.18 (0.53-8.96) | 0.279 |
Medication | ||||
-Beta blockers | 0.38 (0.13-1.17) | 0.092 | 0.93 (0.54-1.61) | 0.805 |
-Calcium antagonist | 0.19 (0.42-3.34) | 0.742 | 1.20 (0.66-2.17) | 0.556 |
-Nitrates | 0.90 (0.30-2.72) | 0.845 | 1.01 (0.54-1.88) | 0.986 |
-Aspirin/clopidogrel | 0.60 (0.23-1.52) | 0.274 | 1.02 (0.60-1.73) | 0.954 |
-ACEI/ARB | 0.70 (0.23-2.13) | 0.531 | 0.87 (0.47-1.5) | 0.644 |
-Statins | 0.60 (0.22-1.59) | 0.301 | 0.71 (0.41-1.23) | 0.216 |
MI by ECG | 7.02 (2.20-22.38) | 0.001 | 1.65 (0.59-4.60) | 0.340 |
CMR variables | ||||
-presence of LGE | 5.74 (2.15-15.33) | < 0.001 | 4.12 (2.23-7.57) | < 0.001 |
-LVEF (per 10% decrement) | 1.39 (0.90-2.14) | 0.135 | 1.19 (0.91-1.56) | 0.208 |
-LVEDVI | 1.007 (1.000-1.014) | 0.041 | 1.006 (1.000-1.011) | 0.038 |
-LVESVI | 1.012 (1.001-1.024) | 0.040 | 1.009 (1.000-1.019) | 0.054 |
-LVMASS index (per quartile) | 2.57 (1.36-6.45) | < 0.001 | 2.11 (1.27-5.56) | < 0.001 |